Apyx Medical Corporation – Filings and Transcripts

NASDAQ: APYX
Share price (7/10/26): $4.38
Market cap (7/10/26): $184 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Shelf registration

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Registration of securities for employees

Ownership Filter

Waldman Lawrence

Roman Shawn David

Levine Wendy Lauren

Vizirgianakis Stavros G.

Goodwin Charles D. II

News Filter

Material Definitive Agreement, Financial Statements or Exhibits

New Study Shows Significant Improvement in Cellulite and Skin Laxity With Advanced Minimally Invasive Treatment Utilizing Avéli® and Renuvion®

Announces Retrospective Clinical Publication Evaluating Clinical Benefit of Renuvion® Used in Combination With Liposuction

Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System™

Reports First Quarter 2026 Financial Results

Proxies Filter

Definitive proxy

Definitive proxy

Preliminary proxy

Definitive proxy

Definitive proxy

Other Filter

Conflict Minerals disclosure

Notice of effectiveness

Correspondence with the SEC

Conflict Minerals disclosure

Conflict Minerals disclosure